MDMA was hyped as a promising treatment for PTSD – what went wrong?
“The future is psychedelic,” declared Rick Doblin, founder of Lykos Therapeutics, at a conference on psychedelic drugs last year. Several studies, many of them funded by Lykos, had provided tantalising signs that pairing MDMA with talk therapy could dramatically reduce symptoms of post-traumatic stress disorder (PTSD). As a result, Doblin was one of many advocates touting the drug as key to revolutionising mental healthcare.
But just a year later,…
You Might Also Like
Human scientists are still better than AI ones – for now
How do AI scientists stack up to human ones?Imaginima/Getty Images Human scientists and engineers can still outperform agents based on...
Hospital hit by Hurricane Milton gets system to grab water from air
Johns Hopkins All Children’s Hospital was hit by Hurricane Milton earlier this weekDirk Shadd/Tampa Bay Times/ZUMA Wire/Alamy A children’s hospital...
Weight-loss drugs lower impulse to eat – and perhaps to exercise too
Weight-loss drugs might make people less inclined to exerciseMe 3645 Studio/Getty Images Semaglutide – the drug in medications like Ozempic...
Qianfan: China’s answer to SpaceX’s Starlink mega constellation is also threatening astronomy
An artist’s impression of the Qianfan satellite mega constellationCCTV China has begun construction of a mega constellation that will eventually...